Alambic Investment Management’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-26,200	Closed	-$496K	–	678
2016 Q4	$496K	Sell	26,200 -500	-2%	-$9.47K	0.09%	334
2016 Q3	$598K	Buy	26,700 +7,900	+42%	+$177K	0.14%	250
2016 Q2	$335K	Buy	18,800 +1,550	+9%	+$27.6K	0.08%	360
2016 Q1	$236K	Buy	+17,250	New	+$236K	0.08%	371